Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies

被引：89

作者：

Chen, Ding ^{[1
]}

Gallagher, Sandra ^{[2
]}

Monson, Nancy L. ^{[1
]}

Herbst, Ronald ^{[3
]}

Wang, Yue ^{[3
]}

机构：

[1] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA

[2] MedImmune, Dept Project Management, Gaithersburg, MD 20878 USA

[3] MedImmune, Dept Oncol Res, Gaithersburg, MD 20878 USA

来源：

JOURNAL OF CLINICAL MEDICINE | 2016年 / 5卷 / 12期

关键词：

CD19; B-cell depletion; autoimmunity; multiple sclerosis; neuromyelitis optica; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; LIVED PLASMA-CELLS; MULTIPLE-SCLEROSIS; CD19; ACTIVATION; MEDI-551; SUBSET; MICE; AQUAPORIN-4; LYMPHOCYTES;

D O I：

10.3390/jcm5120107

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Exaggerated or inappropriate responses by B cells are an important feature in many types of autoimmune neurological diseases. The recent success of B-cell depletion in the treatment of multiple sclerosis (MS) has stimulated the development of novel B-cell-targeting therapies with the potential for improved efficacy. CD19 has emerged as a promising target for the depletion of B cells as well as CD19-positive plasmablasts and plasma cells. Inebilizumab (MEDI-551), an anti-CD19 antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells, is currently being evaluated in MS and neuromyelitis optica. This review discusses the role of B cells in autoimmune neurological disorders, summarizes the development of inebilizumab, and analyzes the recent results for inebilizumab treatment in an autoimmune encephalitis mouse model. The novel insights obtained from these preclinical studies can potentially guide future investigation of inebilizumab in patients.

引用

页数：12

共 74 条

[1] B lymphocytes in neuromyelitis optica [J].

Bennett, Jeffrey L. ;

O'Connor, Kevin C. ;

Bar-Or, Amit ;

Zamvil, Scott S. ;

Hemmer, Bernhard ;

Tedder, Thomas F. ;

von Buedingen, H. -Christian ;

Stuve, Olaf ;

Yeaman, Michael R. ;

Smith, Terry J. ;

Stadelmann, Christine .

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2015, 2 (03) :e104

[2] Myelin oligodendrocyte glycoprote in-specific T and B cells cooperate to induce a Devic-like disease in mice [J].

Bettelli, Estelle ;

Baeten, Dominique ;

Jager, Anneli ;

Sobel, Raymond A. ;

Kuchroo, Vijay K. .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (09) :2393-2402

[3] B-cell targeted therapeutics in clinical development [J].

Blueml, Stephan ;

McKeever, Kathleen ;

Ettinger, Rachel ;

Smolen, Josef ;

Herbst, Ronald .

ARTHRITIS RESEARCH & THERAPY, 2013, 15

[4] Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate [J].

Brueck, Wolfgang ;

Popescu, Bogdan ;

Lucchinetti, Claudia F. ;

Markovic-Plese, Silva ;

Gold, Ralf ;

Thal, Dietmar Rudolf ;

Metz, Imke .

ANNALS OF NEUROLOGY, 2012, 72 (03) :385-394

[5] Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis [J].

Challa, Dilip K. ;

Bussmeyer, Uta ;

Khan, Tarique ;

Montoyo, Hector P. ;

Bansal, Pankaj ;

Ober, Raimund J. ;

Ward, E. Sally .

MABS, 2013, 5 (05) :655-659

[6] Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis [J].

Chen, Ding ;

Ireland, Sara J. ;

Davis, Laurie S. ;

Kong, Xiangmei ;

Stowe, Ann M. ;

Wang, Yue ;

White, Wendy I. ;

Herbst, Ronald ;

Monson, Nancy L. .

JOURNAL OF IMMUNOLOGY, 2016, 196 (04) :1541-1549

[7] Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord while Preserving Peripheral Regulatory Mechanisms [J].

Chen, Ding ;

Blazek, Monica ;

Ireland, Sara ;

Ortega, Sterling ;

Kong, Xiangmei ;

Meeuwissen, Anouk ;

Stowe, Ann ;

Carter, Laura ;

Wang, Yue ;

Herbst, Ronald ;

Monson, Nancy L. .

JOURNAL OF IMMUNOLOGY, 2014, 193 (10) :4823-4832

[8] Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS) [J].

Constantinescu, Cris S. ;

Farooqi, Nasr ;

O'Brien, Kate ;

Gran, Bruno .

BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (04) :1079-1106

[9] GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage [J].

Croxford, Andrew L. ;

Spath, Sabine ;

Becher, Burkhard .

TRENDS IN IMMUNOLOGY, 2015, 36 (10) :651-662

[10] Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease [J].

Dale, Russell C. ;

Brilot, Fabienne ;

Duffy, Lisa V. ;

Twilt, Marinka ;

Waldman, Amy T. ;

Narula, Sona ;

Muscal, Eyal ;

Deiva, Kumaran ;

Andersen, Erik ;

Eyre, Michael R. ;

Eleftheriou, Despina ;

Brogan, Paul A. ;

Kneen, Rachel ;

Alper, Gulay ;

Anlar, Banu ;

Wassmer, Evangeline ;

Heineman, Kirsten ;

Hemingway, Cheryl ;

Riney, Catherine J. ;

Kornberg, Andrew ;

Tardieu, Marc ;

Stocco, Amber ;

Banwell, Brenda ;

Gorman, Mark P. ;

Benseler, Susanne M. ;

Lim, Ming .

NEUROLOGY, 2014, 83 (02) :142-150

← 1 2 3 4 5 6 7 8 →